Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-27 Purchase | 2025-06-30 1:03 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP Bios 2024 Co-Invest LP BP Directors LP Director 10% Owner | 71,428 | $7 | $499,996 | 10,267,884 (Indirect) | View |
| 2025-06-13 Sale | 2025-06-13 7:50 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 40,000 | $3.09 | $123,600 | 140,365 (Indirect) | View |
| 2025-06-10 Sale | 2025-06-13 06:01 am | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 61,613 | $3.3803 | $208,271 | 144,719 (Indirect) | View |
| 2025-05-27 Sale | 2025-05-29 9:53 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 56,237 | $2.9948 | $168,419 | 151,425 (Indirect) | View |
| 2024-08-14 Sale(A) | 2024-08-20 8:46 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $8 | $199,992 | 131,248 (Indirect) | View |
| 2024-08-14 Purchase | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 500,000 | $8 | $4,000,000 | 216,083 (Indirect) | View |
| 2024-08-14 Sale | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $9 | $224,991 | 216,083 (Indirect) | View |
| 2024-05-23 Sale | 2024-05-28 4:31 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 30,000 | $6.3033 | $189,100 | 747,049 (Indirect) | View |
| 2024-02-27 Sale | 2024-02-29 9:54 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 144,000 | $4.6965 | $676,294 | 753,428 (Indirect) | View |
| 2024-01-17 Sale | 2024-01-19 4:30 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 58,889 | $4.2 | $247,334 | 784,013 (Indirect) | View |
| 2023-11-29 Sale | 2023-12-01 06:00 am | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 145,348 | $3.44 | $499,997 | 1,170,117 (Indirect) | View |
| 2022-11-08 Sale | 2022-11-09 9:39 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 350,000 | $4.4 | $1,540,000 | 164,137 (Indirect) | View |
| 2022-09-02 Sale | 2022-09-07 4:54 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 6,445 | $5.2 | $33,514 | 1,889,456 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion